|
Technology allows recovering Tioga teen to attend prom
Journaltrib Bree Hanson, 18, is in Rochester, Minn., continuing her month’s long recovery from heart transplant surgery performed earlier this year. While the Tioga High student was waiting for a new heart to be located to correct a congenital heart problem, she … |
World Biosimilar Sector Developments Traced by FirstWord in New Report … – Virtual-Strategy Magazine (press release)
World Biosimilar Sector Developments Traced by FirstWord in New Report …Virtual-Strategy Magazine (press release)The leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual pro…
Woman to become living donor for man she had never met – WLKY Louisville
Woman to become living donor for man she had never metWLKY LouisvilleThe transplant surgery for Danny and Ashley is scheduled for April 17. Additional information: Living Kidney Donor Network: Click here. Learn about Danny and Ashley and help in their …
UK scientists make body parts in laboratory – The Hindu
|
UK scientists make body parts in laboratory
The Hindu While only a handful of patients have received the British lab-made organs so far, including tear ducts, and windpipes, researchers hope they will soon be able to transplant more types of body parts into patients, including what would be the world’s … |
Curis, Debiopharm Report Anti-Tumor Activity, Synergy with Debio 0932 – Drug Discovery & Development
Drug Discovery & Development |
Curis, Debiopharm Report Anti-Tumor Activity, Synergy with Debio 0932
Drug Discovery & Development Debio 0932 is currently being investigated in a Phase 1/2 trial in combination with SOC agents in patients with advanced NSCLC and in a Phase 1 trial in combination with everolimus, an mTOR inhibitor, in advanced RCC patients. In a high throughput … Curis and Debiopharm Group Report Preclinical Data for Debio 0932 at AACR …PR Newswire (press release) Curis and Debiopharm Group(TM) Report Preclinical Data for Debio 0932 at …Wall Street Journal |
World Biosimilar Sector Developments Traced by FirstWord in New Report … – DigitalJournal.com
World Biosimilar Sector Developments Traced by FirstWord in New Report …DigitalJournal.comThe leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual programmes worldwide. The …
Crohn's sufferer challenges decision to refuse her funding for eggs to be frozen – The Guardian
The Guardian |
Crohn’s sufferer challenges decision to refuse her funding for eggs to be frozen
The Guardian Her barrister told Mr Justice Jay that Rose, who was diagnosed with Crohn’s disease at the age of 14, faces imminent bone marrow transplantation and chemotherapy – treatment she fears will render her infertile. Clinicians at King’s College Hospital in … Woman with Crohn’s disease challenges ‘unlawful’ decision to deny her NHS …Daily Mail Margate artist’s legal action against Thanet health bossesthanetgazette.co.uk Crohn’s woman Lizzie Rose in High Court fertility pleaBBC News |
World Biosimilar Sector Developments Traced by FirstWord in New Report … – PR Web (press release)
World Biosimilar Sector Developments Traced by FirstWord in New Report …PR Web (press release)The leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual programmes worldwide. …
Dedicated Deep Bay biker – Parksville Qualicum Beach News
|
Dedicated Deep Bay biker
Parksville Qualicum Beach News He had a stem cell transplant about six months after his diagnoses in May 2011 but the results weren’t what he was hoping for. His chemotherapy pills will eventually stop working, he said, but thanks to research a new drug called Pomalist recently hit … |
Hypernatremia Linked to Post-Liver Transplant Mortality – Doctors Lounge
Hypernatremia Linked to Post-Liver Transplant MortalityDoctors LoungeTUESDAY, April 8, 2014 (HealthDay News) — Pre-liver transplant (LTx) hyponatremia does not affect post-LTx survival, but hypernatremia is a significant risk factor for post-LTx morta…